Brad Bostic

Eskenazi Health Foundation is a company based out of United States.

ChaCha (www.chacha.com) is the leading free, real-time answers service and has emerged as the #1 way for advertisers to engage with the audience of their choice. Through its unique “ask-a-smart-friend” platform, ChaCha has answered more than a billion questions since launch from more than 32 million unique users per month via online (www.chacha.com), mobile SMS text (242-242), iPhone app, and voice (1-800-2-ChaCha™). Working with major brands such as Paramount, AT&T, Sony, Johnson & Johnson, P&G, Coca-Cola, McDonald’s and hundreds of others, ChaCha is one of the fastest growing mobile publishers according to Nielsen and is ranked in the Top 100 websites according to comScore and Quantcast. ChaCha was co-founded by proven innovator and entrepreneur Scott Jones and is funded by VantagePoint Venture Partners; Rho Ventures; Qualcomm; Bezos Expeditions; Morton Meyerson, former President and Vice Chairman of EDS as well as Chairman and CEO of Perot Systems; Rod Canion, founding CEO of Compaq Computer; the Simon family; and Jack Gill, Silicon Valley venture capitalist.

Ryght’s powerful, global site network of AI Site Twins transforms how sponsors manage site selection and feasibility. Our digital replicas of every research site worldwide enable data-driven decisions that reduce costs and compress timelines.

3Aware supports immediate access to real-world clinical data for medical device manufacturers in a self-administered platform. MedTech Clinical and Regulatory teams spend exorbitant time and money on the real-world data collection to support keeping devices on the market. With a host of patchwork solutions, there remains no solution to meet their clinical data needs reliably, quickly and affordably. The 3Aware solution provides immediate Access to real world data for device encounters, the ability to Analyze the data for inclusion/ exclusion for PMCF reporting and Alerts to safety and performance of devices. Our solution saves Medtech time and money spent on clinical data acquisition for the purpose of Post Market Surveillance.

$200M SPAC led by healthcare technology industry experts focused on disruptive health-tech companies that leverage data science to improve and personalize healthcare.

Better. Faster. Safer.